ARS Pharmaceuticals Inc
SPRY17.450USD
-0.750-4.12%
收盘 06/30, 16:00（美东）报价延迟15分钟
1.71B总市值
214.10市盈率 TTM
关于 ARS Pharmaceuticals Inc 公司
ARS Pharmaceuticals, Inc. 是一家生物制药公司。该公司专注于开发 neffy，用于紧急治疗 I 型过敏反应，包括过敏反应。neffy 是一种专有的肾上腺素组合物，含有一种名为 Intravail 的吸收促进剂，可使 neffy 以小剂量、小剂量和鼻腔喷雾的形式提供类似注射的肾上腺素吸收。I 型过敏反应是可能危及生命的超敏反应，可能在接触过敏原几分钟内发生，需要立即治疗以缓解症状并防止进一步发展。
公司简介
公司代码SPRY
公司名称ARS Pharmaceuticals Inc
上市日期Dec 04, 2020
成立日期2016
CEOMr. Richard E. Lowenthal
员工数量155
证券类型Ordinary Share
年结日Dec 04
公司地址11682 El Camino Real, Suite 120
城市SAN DIEGO
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编92130
电话18587719307
网址https://ars-pharma.com/
公司代码SPRY
上市日期Dec 04, 2020
成立日期2016
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Richard E. Lowenthal
Mr. Richard E. Lowenthal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.83M
-14.34%
Dr. Sarina Tanimoto, M.D.
Dr. Sarina Tanimoto, M.D.
Chief Medical Officer
Chief Medical Officer
4.57M
-10.85%
Mr. Justin Chakma
Mr. Justin Chakma
Chief Business Officer
Chief Business Officer
136.38K
--
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Secretary and Chief Legal Officer
Secretary and Chief Legal Officer
86.26K
-3.33%
Mr. Michael Kelly
Mr. Michael Kelly
Independent Director
Independent Director
83.22K
--
Mr. Brian T. Dorsey
Mr. Brian T. Dorsey
Chief Operating Officer
Chief Operating Officer
7.65K
--
Dr. Laura K. Shawver, Ph.D.
Dr. Laura K. Shawver, Ph.D.
Director
Director
--
--
Dr. Rajeev Dadoo, Ph.D.
Dr. Rajeev Dadoo, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen D. (Kathy) Scott
Ms. Kathleen D. (Kathy) Scott
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Pratik Shah, Ph.D.
Dr. Pratik Shah, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Richard E. Lowenthal
Mr. Richard E. Lowenthal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.83M
-14.34%
Dr. Sarina Tanimoto, M.D.
Dr. Sarina Tanimoto, M.D.
Chief Medical Officer
Chief Medical Officer
4.57M
-10.85%
Mr. Justin Chakma
Mr. Justin Chakma
Chief Business Officer
Chief Business Officer
136.38K
--
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Mr. Alexander A. Fitzpatrick, Esq., J.D.
Secretary and Chief Legal Officer
Secretary and Chief Legal Officer
86.26K
-3.33%
Mr. Michael Kelly
Mr. Michael Kelly
Independent Director
Independent Director
83.22K
--
Mr. Brian T. Dorsey
Mr. Brian T. Dorsey
Chief Operating Officer
Chief Operating Officer
7.65K
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 6月2日 周一
更新时间: 6月2日 周一
持股股东
股东类型
持股股东
持股股东
占比
RA Capital Management, LP
11.06%
Deerfield Management Company, L.P.
10.71%
OrbiMed Advisors, LLC
8.44%
Lowenthal (Richard E)
6.95%
Pratik Shah Living Trust
4.91%
Other
57.93%
持股股东
持股股东
占比
RA Capital Management, LP
11.06%
Deerfield Management Company, L.P.
10.71%
OrbiMed Advisors, LLC
8.44%
Lowenthal (Richard E)
6.95%
Pratik Shah Living Trust
4.91%
Other
57.93%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
20.71%
Hedge Fund
19.64%
Venture Capital
15.20%
Investment Advisor
13.88%
Individual Investor
12.16%
Private Equity
8.44%
Corporation
4.91%
Research Firm
2.18%
Pension Fund
0.27%
Other
2.62%
机构持股
更新时间: 3 小时前
更新时间: 3 小时前
报告期
机构数
持股数
持股占比
持股变动
2025Q2
361
95.98M
97.72%
-8.84M
2025Q1
380
100.63M
102.48%
-12.75M
2024Q4
345
96.62M
99.42%
-14.07M
2024Q3
320
88.19M
90.90%
-18.52M
2024Q2
291
87.17M
89.94%
-20.35M
2024Q1
289
89.45M
92.60%
-16.44M
2023Q4
280
92.18M
96.08%
-6.49M
2023Q3
283
95.82M
104.35%
+1.21M
2023Q2
278
88.26M
96.94%
-730.20K
2023Q1
271
88.79M
98.08%
+1.91M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
10.86M
11.06%
--
--
Mar 31, 2025
Deerfield Management Company, L.P.
10.51M
10.71%
--
--
Mar 31, 2025
OrbiMed Advisors, LLC
8.29M
8.44%
--
--
Mar 31, 2025
Lowenthal (Richard E)
6.83M
6.95%
-1.14M
-14.34%
Mar 31, 2025
Pratik Shah Living Trust
4.82M
4.91%
--
--
Mar 31, 2025
Tanimoto (Sarina)
4.57M
4.66%
-556.66K
-10.85%
Mar 31, 2025
SR One Capital Management, LP
4.01M
4.09%
--
--
Mar 31, 2025
AllianceBernstein L.P.
3.92M
3.99%
+42.07K
+1.08%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.88M
3.95%
-275.85K
-6.63%
Mar 31, 2025
The Vanguard Group, Inc.
3.48M
3.54%
+23.34K
+0.68%
Mar 31, 2025
查看更多
持股ETF
更新时间: 6月6日 周五
更新时间: 6月6日 周五
机构名称
占比
First Trust Small Cap Growth AlphaDEX Fund
0.6%
Janus Henderson Small Cap Growth Alpha ETF
0.39%
First Trust Small Cap Core Alphadex Fund
0.29%
SPDR S&P Biotech ETF
0.24%
iShares Micro-Cap ETF
0.16%
Direxion Daily S&P Biotech Bull 3X Shares
0.16%
ProShares Ultra Nasdaq Biotechnology
0.14%
Invesco Nasdaq Biotechnology ETF
0.14%
First Trust Multicap Growth Alphadex Fund
0.11%
Principal U.S. Small-Cap ETF
0.11%
查看更多
First Trust Small Cap Growth AlphaDEX Fund
占比0.6%
Janus Henderson Small Cap Growth Alpha ETF
占比0.39%
First Trust Small Cap Core Alphadex Fund
占比0.29%
SPDR S&P Biotech ETF
占比0.24%
iShares Micro-Cap ETF
占比0.16%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.16%
ProShares Ultra Nasdaq Biotechnology
占比0.14%
Invesco Nasdaq Biotechnology ETF
占比0.14%
First Trust Multicap Growth Alphadex Fund
占比0.11%
Principal U.S. Small-Cap ETF
占比0.11%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
